These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21247998)

  • 21. Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals.
    Johnson BA; Ait-Daoud N; Ma JZ; Wang Y
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1773-9. PubMed ID: 14634493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HTTLPR moderates naltrexone and psychosocial treatment responses in heavy drinking men who have sex with men.
    Chen AC; Davis CM; Kahler CW; Kuerbis AN; Covault J; Kranzler HR; Morgenstern J
    Alcohol Clin Exp Res; 2014 Sep; 38(9):2362-8. PubMed ID: 25070809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism.
    Laucht M; Treutlein J; Schmid B; Blomeyer D; Becker K; Buchmann AF; Schmidt MH; Esser G; Jennen-Steinmetz C; Rietschel M; Zimmermann US; Banaschewski T
    Biol Psychiatry; 2009 Jul; 66(2):102-9. PubMed ID: 19358979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moderation of baclofen response by a GABA
    Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
    Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of 5-HTTLPR polymorphism in alcohol craving experience.
    Pombo S; Ferreira J; Cardoso JM; Ismail F; Levy P; Bicho M
    Psychiatry Res; 2014 Aug; 218(1-2):174-9. PubMed ID: 24794154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reductions in and relations between "craving" and drinking in a prospective, open-label trial of ondansetron in adolescents with alcohol dependence.
    Dawes MA; Johnson BA; Ma JZ; Ait-Daoud N; Thomas SE; Cornelius JR
    Addict Behav; 2005 Oct; 30(9):1630-7. PubMed ID: 16084024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism.
    Roache JD; Wang Y; Ait-Daoud N; Johnson BA
    Alcohol Clin Exp Res; 2008 Aug; 32(8):1502-12. PubMed ID: 18565156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities of mucosal serotonin metabolism and 5-HT
    Gunn D; Garsed K; Lam C; Singh G; Lingaya M; Wahl V; Niesler B; Henry A; Hall IP; Whorwell P; Spiller R
    Aliment Pharmacol Ther; 2019 Sep; 50(5):538-546. PubMed ID: 31342534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subgroup Identification in Personalized Treatment of Alcohol Dependence.
    Hou J; Seneviratne C; Su X; Taylor J; Johnson B; Wang XQ; Zhang H; Kranzler HR; Kang J; Liu L
    Alcohol Clin Exp Res; 2015 Jul; 39(7):1253-9. PubMed ID: 26031187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA; Roache JD; Ait-Daoud N; Javors MA; Harrison JM; Elkashef A; Mojsiak J; Li SH; Bloch DA
    Drug Alcohol Depend; 2006 Oct; 84(3):256-63. PubMed ID: 16631323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals.
    Mannelli P; Patkar AA; Murray HW; Certa K; Peindl K; Mattila-Evenden M; Berrettini WH
    Addict Biol; 2005 Sep; 10(3):261-8. PubMed ID: 16109588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can serotonin transporter genotype predict craving in alcoholism?
    Ait-Daoud N; Roache JD; Dawes MA; Liu L; Wang XQ; Javors MA; Seneviratne C; Johnson BA
    Alcohol Clin Exp Res; 2009 Aug; 33(8):1329-35. PubMed ID: 19426172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.
    Kranzler HR; Armeli S; Tennen H; Covault J; Feinn R; Arias AJ; Pettinati H; Oncken C
    J Clin Psychopharmacol; 2011 Feb; 31(1):22-30. PubMed ID: 21192139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study.
    Kranzler HR; Pierucci-Lagha A; Feinn R; Hernandez-Avila C
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1150-5. PubMed ID: 12878921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin and alcohol drinking.
    Sellers EM; Higgins GA; Tompkins DM; Romach MK
    NIDA Res Monogr; 1992; 119():141-5. PubMed ID: 1435969
    [No Abstract]   [Full Text] [Related]  

  • 36. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder.
    Hartwell EE; Feinn R; Morris PE; Gelernter J; Krystal J; Arias AJ; Hoffman M; Petrakis I; Gueorguieva R; Schacht JP; Oslin D; Anton RF; Kranzler HR
    Addiction; 2020 Aug; 115(8):1426-1437. PubMed ID: 31961981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ondansetron alters human alcohol intoxication.
    Swift RM; Davidson D; Whelihan W; Kuznetsov O
    Biol Psychiatry; 1996 Sep; 40(6):514-21. PubMed ID: 8879472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional genetic variants that increase synaptic serotonin and 5-HT3 receptor sensitivity predict alcohol and drug dependence.
    Enoch MA; Gorodetsky E; Hodgkinson C; Roy A; Goldman D
    Mol Psychiatry; 2011 Nov; 16(11):1139-46. PubMed ID: 20838391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.
    Heinz A; Jones DW; Mazzanti C; Goldman D; Ragan P; Hommer D; Linnoila M; Weinberger DR
    Biol Psychiatry; 2000 Apr; 47(7):643-9. PubMed ID: 10745057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.